IS THIS CHINESE OUTFIT COLLECTING DNA FROM AUSSIE COVID-19 TESTS?
By Tony Mobilifonitis
CHINA’S Beijing Genomics Institute (BGI), which collects DNA forcibly harvested from Chinese people, is a major security risk to Australia, according to documents sourced by Melbourne lawyer and activist Serene Teffaha.
BGI has sold 10 million COVID-19 testing kits to Australia with the help of Andrew Forrest’s Minderoo Foundation. There has been much speculation about whether the kits could be used as part of a DNA harvesting operation.
BGI exploited the COVID crisis early this year by selling 35 million rapid testing or RT-PCR kits to 180 countries and building 58 labs in 18 countries, including 11 in Australia in Sydney, Melbourne, Brisbane, Adelaide, Perth, Wollongong, and Hobart.
BGI’s news centre reported these Australian labs process and test all the COVID-19 test samples “from all states and territories in a timely fashion”.
The big Australian mass-testing plan was in place by April with TGA approvals. BGI lab equipment was transported from China on 10 Minderoo chartered flights, along with “a team of experienced BGI technical specialists and engineers who hail from various parts of China to provide training and technical support to the local Australian counterparts”.
BGI’s main laboratory and headquarters are in Brisbane, between the Clive Berghoffer Medical Research Institute and the Nucleus Network Brisbane Clinic on Herston Road, near the Royal Brisbane and Women’s Hospital.
The company opened its first Southern Hemisphere lab at the site in 2017, where it carries out RNA sequencing, which is used in medical and other genomic research.
Indian media have warned of US genomics companies being linked to the mass harvesting of male DNA by police and other government agencies across China.
In a recent online interview between Teffaha and the green-tinged Health Australia Party, Teffaha said the Australian Strategic Policy Institute, which studies security risks and major contracts involving the nation, warned the government in a report that BGI was DNA profiling for the Chinese government. “They’re actually building a police-run DNA database,” Teffaha said.
“I’ve got all the reports – they are all online. The Australian Strategic Policy Institute warned the government of the security risks of using the RT-PCR tests, the 10 million of them they’ve brought in, for the fact that the BGI is related very strongly to companies that are engaging in DNA dragnets – profiling DNA.
“That’s right. The RT-PVR tests are not so reliable for testing COVID but they are pretty good at getting your DNA information.”
Whether or not BGI is covertly accessing the DNA from Australian COVID testing is not known, but businesses controlled by Chinese Communist Party cannot be trusted as pure, profit-seeking private enterprise.
BGI had been seeking to expand its genome sequencing services and is involved in a legal stoush with the US-based genomics company Illumina, which describes itself as “a provider of sequencing and array-based solutions for genetic analysis”.
This raises questions of a bigger issue here around the new eugenics movement with companies developing all sorts of genetics-based medical treatments including the horrific new vaccines that meddle with human RNA and DNA.
Health Minister Greg Hunt says the COVID-19 tests are protected by privacy laws that cover pathology tests and patient data. BGI’s equipment had also been approved by security agencies. “BGI will have no access to patient information as they will not be operating the labs,” a spokesman for the minister said in a statement. Pathology companies were required to comply with security agency advice on installing BGI’s technology.
The Times of India reported on July 24 that DNA was being harvested across China by police collecting blood from children, pinpricking their fingers at schools, while official documents showed DNA samples were also being gathered in major urban centers.
The paper said an official report from the Sichuan Province government website, detailed the creation of a DNA database by the Public Security Bureau of the city of Chengdu, the province’s capital, and sought expert opinion on the creation of a “male ancestry investigation system.”
“It documents how 17 public security offices have collected DNA samples from nearly 600,000 male residents across the city — that’s about 7 percent of Chengdu’s male population (assuming that roughly half of the city’s total population of about 16.6 million is male).
“The Chengdu procurement report states that building a massive genetic database about local residents will help the police “maintain public order and stability as well as meet the needs of daily case work.” This is of no comfort,” TOI reported.
The paper said evidence continues to accumulate that private companies, both Chinese and foreign, are complicit in “this extraordinarily vast, and ominous, assault on the privacy of Chinese citizens”.
In Hunan Province, Huangrui Scientific Instruments Ltd. — a company based in the provincial capital that produces a range of medical, chemical and scientific products — has sold to the Public Security Bureau of the city of Liuyang some 140,000 DNA testing kits produced by Thermo Fisher Scientific, a US-based Fortune 500 company. That’s enough equipment to test roughly one in five men in the community.